胃癌中的Wnt信号:目前的进展和未来的前景
Ruyue Han1, Jing Yang2, Yingying Zhu1
1Cancer Research Institute, Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
Frontiers in oncology
|July 2, 2024
概括
改变的Wnt通路信号驱动胃癌的进展,入侵和化学抵抗. 了解这些分子机制对于开发针对性治疗这种恶性瘤至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症信号传递 癌症信号传递
背景情况:
- 异常的Wnt通路成分水平是胃癌的标志.
- 这些变化促进恶性细胞的增殖,入侵和转移.
- Wnt通路的失调与胃癌患者的不良预后和化疗抵抗有关.
研究的目的:
- 系统地审查Wnt信号传递在胃癌发展中的分子机制.
- 总结目前关于Wnt通路分子剂的研究进展.
- 确定针对胃癌治疗的Wnt途径的挑战.
主要方法:
- 对胃癌中Wnt通路机制的系统文献综述.
- 分析分子剂开发的研究进展和挑战.
- 综合了关于Wnt信号传递在胃癌发病过程中的作用的发现.
主要成果:
- 该Wnt通路是胃癌细胞行为的一个关键调节器.
- 调节障碍对瘤进展和治疗耐药性有显著的作用.
- 针对Wnt路径的分子剂的研究正在进行中.
结论:
- 准Wnt通路对胃癌具有治疗潜力.
- 需要进一步的研究,以克服开发有效分子剂的挑战.
- 对Wnt信号的更深入的理解对于改善患者的治疗结果至关重要.
更多相关视频
03:05Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.0K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
相关概念视频
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
